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Abstract
(TS), responsible for porcine cysticercosis, human taeniasisTaenia solium 
and (neuro)cysticercosis, was included in the World Health Organization
neglected tropical disease (NTD) roadmap published in 2012. Targets set
in this roadmap have not been met, but   has been included in theT. solium
consultation process for the new 2030 goals proposed for priority NTDs. 
 transmission dynamics models can contribute to thisTaenia solium
process. A recent review has compared existing   transmissionT. solium
models, identifying their similarities and differences in structure,
parameterization and modelled intervention approaches. While a formal
model comparison to investigate the impact of interventions is yet to be
conducted, the models agree on the importance of coverage for
intervention effectiveness and on the fact that human- and pig-focused
interventions can be optimally combined. One of these models, cystiSim,
an individual-based, stochastic model has been used to assess
field-applicable interventions, some currently under evaluation in on-going
trials in Zambia. The EPICYST, population-based, deterministic model has
highlighted, based on simulating a generic sub-Saharan Africa setting, the
higher efficacy (measured as the percentage of human cysticercosis cases
prevented) of biomedical interventions (human and pig treatment and pig
vaccination) compared to improved husbandry, sanitation, and meat
inspection. Important questions remain regarding which strategies and
combinations thereof provide sustainable solutions for severely
resource-constrained endemic settings. Defining realistic timeframes to
achieve feasible targets, and establishing suitable measures of
effectiveness for these targets that can be quantified with current
monitoring and evaluation tools, are current major barriers to identifying
validated strategies.   transmission models can supportTaenia solium
setting achievable 2030 goals; however, the refinement of these models is
first required. Incorporating socio-economic elements, improved
understanding of underlying biological processes, and consideration of
spatial dynamics are key knowledge gaps that need addressing to support
model development.
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CLTS, community-led total sanitation intervention; DALY, dis-
ability-adjusted life year; EOT, elimination of transmission; 
FOI, Force-of-infection; MDA, mass drug administration; 
M&E, monitoring and evaluation; NCC, neurocysticerco-
sis; NTD, neglected tropical disease; PCC, porcine cyst-
icercosis; PAHO, Pan American Health Organization; SAC, 
school-age children; SSA, sub-Saharan Africa; TS, Taenia 
solium; WHO, World Health Organization; zDALY, zoonotic 
disability-adjusted life year.
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Background
Taeniasis and (neuro)cysticercosis are infections caused by 
the cestode Taenia solium (TS), involving a complex transmis-
sion cycle between the intermediate pig host and the defini-
tive (also accidental intermediate) human host. When humans 
act as the accidental intermediate host, localization of lar-
val-stage cysticerci in the central nervous system can result in 
neurocysticercosis (NCC), the main condition contributing 
to TS-associated morbidity and mortality, including epileptic 
seizures/epilepsy. TS is endemic across Latin America, sub- 
Saharan Africa (SSA), and Asia, especially South and South East 
Asia, in settings with low hygiene conditions where open def-
ecation practices prevail and/or sanitation systems are insufficient 
to prevent exposure of infective material in human faeces to 
pigs1. Most recent estimates of disease burden indicate that TS 
resulted in 1.61 (95% uncertainty interval=1.05–2.23) mil-
lion disability-adjusted life years (DALYs) globally in 2017 
for NCC-associated morbidity and mortality2. This likely rep-
resents a substantial underestimation based on the difficul-
ties inherent to assessing NCC prevalence and the way that 
disability weights have been attributed to NCC, which need to 
consider not only epilepsy but, at a minimum, also headache and 
neuropsychiatric co-morbidities3–5. Recent reviews have sug-
gested that TS may also be present in other regions, such as 
Eastern Europe6. Large economic consequences do not only 
pertain to the human public health sector, but also to the 
animal sector, resulting from reduced market value and mar-
ket distortion associated with pig infection in the food-value 
chain, which disproportionately impacts the poorest farmers and 
communities7–12.
A variety of intervention options are available to tackle TS 
transmission in endemic settings. In the pig host, vaccines are 
available including TSOL18, alongside anthelmintic treat-
ment using oxfendazole13. The TSOL1814 vaccine has been 
licenced and made commercially available in India since 
November 2016, with registration underway in Uganda, Tanzania, 
Kenya, Nepal, Philippines, Thailand, and Sri Lanka, while 
oxfendazole was registered in Morocco for treatment against 
porcine cysticercosis (PCC) in June 2013 (see WHO article on 
ParanthicTM and CysvaxTM). Intervention options under consid-
eration include treatment of human taeniasis carriers based on 
mass drug administration (MDA) or on targeted treatment with 
either praziquantel or niclosamide13. These treatments, e.g. prazi-
quantel, could potentially be integrated with other neglected 
tropical disease (NTD) programs15, such as those for schisto-
somiasis and soil-transmitted helminthiases. However, possi-
ble adverse neurological outcomes associated with treatment of 
NCC cases, especially at higher doses, may restrict the util-
ity of praziquantel. Further structural changes/interventions that 
generate broader positive externalities such as impacting TS 
transmission, include improved sanitation and pig husbandry 
practices; however, their wide-scale implementation will 
mostly depend on longer-term economic development16. Health 
education, such as the computer-based educational tool ‘The 
Vicious Worm’17, provides a low-cost, locally-adaptable, and 
implementable intervention for both short- and longer-term impact. 
Studies demonstrate improved and sustained knowledge uptake 
in Tanzanian health- and agriculture-sector professionals18,19, 
as well as in rural Zambian primary-school children20. 
Other community-based participatory educational interven-
tions in Burkina Faso have also demonstrated a marked reduc-
tion in human cysticercosis incidence and prevalence21. A 
community-led total sanitation (CLTS) intervention in Zambia 
did not reduce porcine cysticercosis prevalence, with sanitation 
practices and cysticercosis awareness largely unchanging22, 
further indicating the importance of knowledge uptake. A 
recent systematic review analysed the available evidence on 
the effectiveness of TS intervention options23, concluding that 
combined human- and pig-focussed interventions are the most 
promising strategies for achieving rapid declines in infection24 
and enhancing prospects for regional elimination25. This 
further supports the argument for a One Health approach, 
including humans and non-human animals as well as the envi-
ronment. In addition, integrated knowledge translation, where 
knowledge-users work with researchers throughout the research 
process26, as well as contextualized policy- and practice- 
transfer mechanisms seem important for sustainability of the 
obtained results. In 2012, the World Health Organization (WHO) 
NTD roadmap called for the establishment of a validated 
strategy for TS control and elimination by 2015, and for inter-
ventions to be scaled up in selected countries by 202027. How-
ever, a validated strategy has not yet been established. There 
are currently TS pilot control programs under assessment in 
Madagascar, with pilots also planned for Vietnam and China28. 
Currently, there are no specific TS programmatic goals as 
identified for other NTD programs, reflecting the relatively 
early stage of consolidation of an optimal disease control strategy 
compared to other NTDs.
A recent WHO consultation was held to gather evidence 
to support a new NTD roadmap for post-2020 targets and 
milestones. Transmission dynamics models can help address 
evidence gaps by assessing, in silico, the feasibility and 
potential impact of different intervention strategies to achieve 
proposed 2021–2030 targets. Dixon et al.29 recently conducted a 
systematic review and analysis of available TS transmission 
models, identifying four mathematical/computational/statistical 
models (among them three transmission dynamics models), and 
a conceptual ‘logical’ framework30. Models included a decision-
tree31, Reed-Frost32, individual-based33, and population-based34 
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frameworks. (Other models have been published since this 
review35,36.) On-going development of cystiSim33 and EPICYST34 
within a collaborative umbrella, has led to the establish-
ment of ‘CystiTeam’, a partnership between the groups that 
developed these two models (based at the University of 
Copenhagen/Scientific Institute of Public Health, Brussels, 
and Imperial College London, respectively) and groups of 
epidemiologists, veterinarians, clinicians, one-health experts and 
program stakeholders. With the development of the new 2030 
NTD goals in mind, Table 1 outlines the current NTD goals 
for TS (2015, 2020) and the proposed goals for 2030, with 
a summary of their technical feasibility, requirements, and 
most prominent knowledge gaps and associated risks.
Insights gained from TS transmission dynamics 
modelling
A quantitative comparison of TS transmission dynamics mod-
els has not yet been performed, and therefore it is not possi-
ble to formally compare the (cystiSim and EPICYST) models 
at this stage (an aim of the CystiTeam partnership). The lack of 
standardised programmatic targets also restricts the ability to 
determine the effectiveness of different interventions with the 
available modelling frameworks. Current models, however, do 
shed some light on the potential impact of interventions under 
more generalised, illustrative scenarios. The population-based, 
deterministic, transmission model EPICYST34 has highlighted, 
based on simulating a generic SSA setting, the higher effi-
cacy (measured as the percentage of human cysticercosis 
cases prevented) of biomedical interventions (human test-and-
treat, pig MDA and pig vaccination) compared to structural 
change-based interventions (improved husbandry, sanitation 
and meat inspection), although insufficient data and knowledge 
currently exist to parameterize accurately the latter (Figure 1). 
In EPICYST34, further developments are on-going to reflect 
age-specific stratification of interventions such as pig vaccina-
tion scheduling and to test the impact of praziquantel MDA 
in school-age children (SAC). cystiSim33, an agent-based, 
stochastic, model is able to simulate age-structured, field- 
realistic interventions as well as bespoke treatment efficacy 
for varying settings. cystiSim has identified, within the context 
of an endemic district in Tanzania, that two-host interventions 
(human MDA plus pig vaccination and treatment), are optimal 
strategies to achieve elimination of transmission (EOT) if 
high coverage can be reached and sustained for prolonged 
periods33. Both EPICYST34 and cystiSim33 agree that pig- and 
human-directed interventions are sensitive to coverage levels. 
Biomedical interventions were identified as more robust to 
changes in both coverage and efficacy compared to structural 
change-based interventions in EPICYST34, although model-
ling of the latter requires collection of robust data. cystiSim33 
Table 1. Summary of modelling insights and challenges for reaching the World Health Organization (WHO) 2030 goals for Taenia 
solium taeniasis/cysticercosis.
Current WHO Goal: Validated strategy for control of Taenia solium (TS) taeniasis/cysticercosis available (2015)27. 
Interventions scaled up in selected countries for T. solium taeniasis/cysticercosis control (2020)27.
2030 Target: Endemic countries with intensified control in hyperendemic areas.
Is the new target technically 
feasible under the current 
disease strategy?
Difficult to ascertain as the optimal combination of intervention strategies for intensified control has not 
yet been established/validated, specific programmatic goals have not been proposed, and the extent 
of hyperendemic areas in endemic countries has not yet been delineated. 
Modelling can inform the design and evaluation of pilot and large-scale control programs with current 
(and complementary) intervention strategies in settings of varying endemicity, as well as contribute to 
the identification of optimal combinations of interventions29,33–37. 
cystiSim and EPICYST applicable, with cystiSim already in use (Zambia/PAHO)33,37.
What is required to achieve 
the target? (updated strategy, 
use of new tools, etc.)
Standardised definition of programmatic goals for TS control put forward by WHO/expert group. 
Standardised monitoring protocols to evaluate progress of intervention strategies. 
Long-term intervention approaches to asses long-term epidemiological impact.
Are current tools able to 
reliably measure the target?
Substantial limitations with existing serological diagnostics (for the assessment of prevalence in 
humans and pigs), and broader access including neuroimaging facilities (for the assessment of 
disease burden). 
Necropsy in pigs most reliable measure of infection in the porcine population, but limitations remain in 
terms of assessing interventions’ long-term effectiveness (models can assist). 
Lack of treatment and management guidelines for taeniasis/(neuro)cysticercosis.
What are the biggest 
unknowns?
In which areas infection is present; true prevalence in humans and pigs (due to poor diagnostics/lack of 
necropsy data) within endemic areas. 
Adult tapeworm lifespan; impact of pig-to-people population ratio on transmission; processes 
regulating parasite acquisition in humans and pigs35, influence of environment on egg dynamics. 
Health & economic burden7,8 and cost-effectiveness of interventions (DALYs likely to underestimate 
disease burden); possible use of the zDALYs metric38. Linking infection to disease models, particularly 
to human neurocysticercosis (NCC) and epilepsy29.
What are the biggest risks? Long-term sustainability of interventions is uncertain.
WHO: World Health Organization, TS: Taenia solium, PAHO: Pan American Health Organization, DALY: Disability-Adjusted Life Year, zDALY: Zoonotic Disability-
Adjusted Life Year, NCC: neurocysticercosis.
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showed that coverage is particularly important when interven-
tions target a single host, but the addition of an intervention 
targeting the second host can compensate for lower coverages33. 
More recently, Braae et al.39 used cystiSim33 to explore inter-
vention simulations deemed to be closely aligned to the 
(assumed) population biology of the parasite; for example, 
testing a combined pig intervention (TSOL18 vaccine and 
oxfendazole MDA) for a duration of 3 years to reflect the 
modelled average lifespan of the adult tapeworm40. The EOT prob-
ability was >90% in this scenario (coverage: 75%; frequency: 
3-monthly; duration: 3 years), suggesting a role for pig-
only strategies if these can be implemented at high cover-
age and frequency for sufficiently long. This modelling study 
also indicated that the program duration could be reduced to 
2 years with a similar EOT probability (>85%) with addition of 
human MDA after the first year (coverage: 80%; frequency: 
6 monthly; no. of treatment rounds: 3; duration: 2 years). 
Inclusion of pig-focussed interventions (with or without 
human MDA) was substantially more effective than human 
MDA-only strategies (coverage: 80%; frequency: annual or 
6-monthly; duration: 5 or 10 years) (Figure 2).
Use of TS transmission models to support 
intervention trials and programs
cystiSim has been used to inform potential control activi-
ties under the Pan American Health Organization (PAHO) 
and to support intervention design (intervention selection, 
coverage, frequency, duration) and assessment of options under 
consideration in the community-based intervention pilot project 
‘CYSTISTOP’ in Zambia. CYSTISTOP commenced in 2015 
and is due to end in 202041. Modelling comparisons exam-
ine different intervention strategies, including mass or targeted 
treatment programs assumed to be feasible in ‘lower 
input/investment’ systems versus more intensive elimina-
tion strategies which focus on combined, higher-frequency 
interventions36. Yearly pig oxfendazole MDA strategies (drug 
efficacy: 100%; therapeutic coverage: 90% of pigs aged ≥2 
months; frequency: annual; no. rounds: 12; duration: 12 years) 
provided the most effective ‘control’ approach (EOT prob-
ability =75%), compared to human praziquantel MDA (drug 
efficacy: 95%; therapeutic coverage: 85% of humans aged ≥5 
years; frequency: annual; no. rounds: 12; duration: 12 years), 
with EoT probability=1%. In terms of highly intensive elimina-
tion options, combined interventions (human and pig MDA with 
drug efficacy and coverage as above plus pig vaccination; fre-
quency: 4-monthly; no. rounds: 6; duration: 2 years) was the most 
effective (EOT probability =96.5%) (Figure 3). These simulated 
interventions will be evaluated using the final CYSTISTOP results 
for model validation.
Considerations and barriers towards 2030 TS goals: 
the role of modelling
Measuring the target
1) Timelines and feasibility of control goals.
Currently, a lack of internationally agreed goals (elimination 
as a public health problem, or elimination of transmission 
Figure 1. Impact of single interventions on the number of human cysticercosis cases. Box and whiskers represent the range of impact 
estimates from 1000 sensitivity draws of intervention efficacy parameters, the midline represents the median impact, the hinges the 25th 
and 75th percentiles, and the whiskers the range. Points show individual run outputs. Due to the large amount of uncertainty in parameters 
estimates, the impact of parameter estimates was explored separately (see Figure 4 in Winskill et al.23). This figure has been reproduced 
under the Creative Commons Attribution 4.0 International License (CC BY 4.0) from Winskill et al.23.
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Figure 2. Simulation of various control scenarios for Taenia solium using cystiSim. The effectiveness of repeated mass drug 
administration (MDA) in humans (H) for taeniasis is compared with three-monthly interventions in pigs (P) involving vaccination and treatment, 
or a combination of pig interventions with strategic MDA in the human population after 1000 simulations (S). The impacts are shown on 
porcine cysticercosis (PC), immunity to T. solium infection in the pig population (PR), and human taeniasis (HT). The colored areas delineate 
the 95% uncertainty intervals for prevalence. Pr(elim) indicates the predicted probability of elimination of transmission (EOT) in the given 
scenario. Four scenarios are simulated which involve: MDA only in humans (A–D): annual treatments for 5 or 10 consecutive years (A and 
B, respectively), and biannual MDA for 5 or 10 consecutive years (C and D, respectively). Two scenarios involve pig-focussed interventions. 
Each included three-monthly vaccination and oxfendazole treatment of the pig population. The first involves: vaccination and treatment in 
pigs (E) for 3 years. The second (F) also involves pig interventions, but includes three human MDA rounds, at 6, 12, and 18 months after the 
initiation of the interventions in pigs, over a total period of 2 years. This figure has been reproduced with permission from Braae et al.31.
targets) curtail the identification of a validated TS control/ 
elimination strategy. Closely linked to identifying specific 
goals is a clarification of the suitability of different strategies 
according to epidemiological setting, and the timeframes 
available to implement these strategies. Longer-term, lower 
input/investment ‘control’ options, implemented over many 
years are potentially more attractive in severely resource- 
constrained settings37; however, these will require long-term politi-
cal and financial support. Similar epidemiological outcomes could 
potentially be achieved under more intensive, shorter-duration 
interventions39. Therefore, classifying feasible timeframes to 
achieve national and regional control goals42, aligned not only 
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Figure 3. cystiSim output for different intervention scenarios aiming for control and elimination of Taenia solium in Zambia. Interventions 
aiming for control (A) and elimination (B): Pr(elim): probability of elimination of transmission (EOT) of porcine cysticercosis (PCC) and human 
taeniasis (HT), MDA: human mass drug administration (praziquantel), OXF: porcine mass drug administration (oxfendazole), VAC: porcine 
vaccination (TSOL18), XqY: total number of X iterations of the intervention given at intervals of Y months. Interventions are introduced after 
200 months. This figure has been reproduced with permission from Gabriël et al.25.
to epidemiological/ecological settings, but also to realistic 
operational, logistic, economic and political conditions, will 
be an important precursor to testing and identifying setting-
specific strategies. With the proposed overarching target of 
achieving “intensified control in hyperendemic settings”, 
technical definitions of endemicity levels are required, with 
subsequent mapping to identify hyperendemic areas within 
endemic countries. “Intensified control” will also need a tech-
nical definition; for example, achieving a proposed percentage 
prevalence or incidence reduction, or agreeing on what are the 
infection levels in humans and pigs that lead to a public/veterinary 
health problem. The level of intensified control will also 
need to be locally adaptable to conform to variable levels 
of resource constraints under realistic timeframes set within 
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the 2020–2030 period. Collaboration between TS modelling 
groups and groups responsible for intervention trials, as dem-
onstrated for CYSTISTOP in Zambia37, can underpin model 
validation efforts, which would ultimately improve the predic-
tive ability of TS transmission models. This will be an impor-
tant step for projecting the impact of interventions under 
realistic timeframes, and therefore for identifying validated 
strategies, in a wider range of endemic settings.
2) Measures of effectiveness, diagnostic applications and limita-
tions.
cystiSim, which has been used to simulate interventions in 
Tanzania33,39 and Zambia37, models effectiveness in terms of 
the probability of achieving (local) elimination. Agreement 
needs to be reached on the validity of measures of effective-
ness in field settings given the significant limitations of cur-
rently available diagnostic tools. Current serological methods are 
suboptimal for the diagnosis of PCC, lacking both specificity in 
areas where other Taenia species exist43,44 and sensitivity, 
particularly to light infections45, restricting their use in near-
elimination settings. Necropsy, consisting of full-carcass 
dissection for presence (and enumeration of cysterci), is the 
gold standard diagnostic for porcine PCC. However, necropsy 
is not suitable as a routine monitoring and evaluation (M&E) 
tool for control programs given the large number of animals 
required to detect a statistically meaningful impact on trans-
mission. Such large necropsy sample sizes, removed from the 
general pig population, would (artefactually) influence trans-
mission and local food-value chains42. Different diagnostic 
methods may be more appropriate depending on transmission 
setting and stage of control. For epidemiological mapping of 
high-risk settings, pig tongue inspection may be suitable for 
identifying heavily infected animals and could play a wider 
role as a potential tool for rapid epidemiological assessment46. 
As interventions are established in settings with moderate 
to high transmission, pigs of minimum slaughter age or 
weight can be initially screened, with a further sub-sample 
necropsied42,47, as implemented in the elimination trial in 
Northern Peru25. Equally, limitations exist for human taeniasis 
diagnostics, including microscopy, coprology and antibody 
serology technology, with specificity issues in particular prov-
ing problematic for M&E purposes in typical endemic settings, 
where endemic taeniasis prevalence does not exceed 2%47. 
Therefore, a crucial challenge for determining the effective-
ness of intervention programs is defining what is meant by 
success and how proposed targets can be measured using avail-
able (or novel) diagnostic tools. Simulating the impact on trans-
mission of control programs using mathematical models can 
help to assess whether “intensified control” could firstly be 
achieved with transmission dynamics in humans and pigs as 
observable in the field (adjusted by diagnostic characteris-
tics), and, secondly, what would be the prospects for local true 
elimination were this possible in a specific location.
Developing tailored, setting-specific strategies
1) Local practices.
Socio-cultural practices influence the TS transmission sys-
tem, and as such, highlight requirements for tailored setting- 
specific intervention programs. One key area relates to the age/
weight at which pigs are slaughtered and consumed, which 
varies dramatically and is suggested to heavily influence the 
effectiveness of pig-directed interventions30. Cultural, reli-
gious and farming practices may also impact the timing of pork 
consumption30,48, and, therefore, improving knowledge of these 
practices and how they vary geographically could be used to 
construct a ‘pork consumption calendar’30. This, in turn, could be 
used to inform appropriate interventions, particularly regarding 
the timing of pig-directed interventions prior to peak pork-
consumption periods. Health education will also be setting- 
dependent given varying husbandry and sanitation practices, 
and it would be highly valuable to test its impact with the 
transmission dynamics models as and when data become 
available on the impact of health education on TS transmission.
2) Spatial elements.
Spatial heterogeneity in the epidemiology of TS has been 
identified both at very small local scales and at higher spa-
tial resolutions. Particularly in South American communities, 
local clustering of PCC49 around human taeniasis carriers is a 
feature50–52 which needs more investigation in other locations. 
Local movement of pigs along value chains and human migra-
tory patterns influence transmission at different scales and 
impact the prospects of elimination and resurgence31. TS trans-
mission models featuring spatial structuring could evaluate the 
impact of spatially heterogeneous transmission (at a variety 
of scales) on intervention effectiveness. At the highest spatial 
resolutions, a detailed overview of national/global distribution 
of TS is also lacking. CystiTeam members are currently 
working on models to inform on the global distribution of 
TS with the aim to map out areas in need of intervention and more 
accurately estimate the global burden of disease due to TS.
Sustainability of intervention strategies
1) Integration with other NTD programs.
The cross-utility of anthelmintic drugs to target multiple 
helminth species presents opportunities for integration of NTD 
control programs. Co-distribution of schistosomiasis and TS has 
been identified in 17 African countries53, while the presence of 
national-scale schistosomiasis control programs in more than 30 
African countries presents opportunities for co-treatment of both 
helminths with praziquantel, albeit with risks of serious adverse 
events associated with NCC cases [ASW, unpublished data]. 
Over a 4-year period, the impact of the National Schistosomiasis 
Control Programme in two endemic districts of Tanzania, target-
ing SAC, alongside a taeniasis “track-and-treat” intervention 
suggested a wider spillover impact on adult human taeniasis 
carriers and PCC prevalence15. cystiSim simulated a school-
based MDA for one of these districts, indicating that there was 
little impact on PCC prevalence and minimal impact on human 
taeniasis33. These results indicate that a TS intervention con-
strained to targeting SAC (within an integrated school-based NTD 
program) would have limited impact on TS transmission, and 
will require additional TS-specific interventions to be effective. 
Reviewing taeniasis age-prevalence profiles and fitting Force-
of-Infection (FOI), catalytic models may help elucidate 
whether age-targeted approaches are more effective in other 
epidemiological settings29.
2) Cost implications and impact assessments.
Determining the most cost-effective interventions for TS 
requires further investigation. The ability to determine the rela-
tive cost-effectiveness compared to other NTD interventions 
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will help to formulate an economic case for inclusion of TS 
control activities in national disease-control policies. Classical 
measures of cost-effectiveness, such as cost per DALY averted 
for different intervention options will be difficult to assess, 
as studies on longer-term impact on human cysticercosis 
incidence39 and occurrence of NCC-related morbidity are dif-
ficult to implement. TS burden of disease and cost-impact 
studies have been conducted, focussing just on NCC human 
health impact in Mexico54 and India55, and more comprehen-
sive assessments capturing costs in both human health and 
agricultural sectors in Tanzania7, Mozambique8, Cameroon56, 
and South Africa11. More recently, combined burden assess-
ments using a zoonotic DALY framework (zDALY)38 have 
been devised and implemented in Cameroon, and used to 
determine the cost-effectiveness of TS interventions in Lao 
People’s Democratic Republic57. TS transmission dynam-
ics models provide added benefit by enabling dynamic (rather 
than static) burden of disease assessments. A key challenge 
here is linking human cysticercosis infection to morbidity 
because of the varying proportions of individuals developing 
morbidity, the time between exposure and disease onset, the 
highly pleomorphic nature of clinical NCC and the lack of neu-
roimaging facilities in resource-constrained settings to enable 
data collection alongside improved diagnostics29. In the short-
term, it is likely that designing cost-effectiveness studies on 
outcomes related to changes in PCC prevalence and human 
taeniasis indicators will be more feasible, but this will 
probably require superior diagnostic tools compared to those 
currently available.
Future directions
Addressing existing models’ structural and parametric uncer-
tainty is a critical step towards enabling such models to increase 
their predictive capacity to assess the 2030 TS targets and pro-
vide robust support. There are several frameworks available29–36 
with groups in CystiTeam working on improving the cysti-
Sim and EPICYST models collaboratively. Knowledge gaps 
have been highlighted to further model development, includ-
ing age-specific infection trends and local practices to inform 
setting-specific parameterization. Other biological param-
eters requiring further investigation include the average and 
distribution of the adult tapeworm lifespan, processes regulat-
ing parasite acquisition in humans and pigs, and exposure het-
erogeneity, which may manifest as aggregated (overdispersed) 
infection distributions at the population level (as attested by the 
distribution of cysticerci in pig populations46,58,59). Identifying 
how current demographic assumptions impact transmission, such 
as the pig-to-people population ratio, need to be systematically 
tested between current TS transmission models. Figure 4 presents 
key research gaps and data needs to move the field forward.
Figure 4. Lifecycle of Taenia solium. The lifecycle indicates, at each stage, key research gaps and data needs important for epidemiological 
modelling. This figure has been reproduced under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0) from Dixon et al.29. 
NCC: neurocysticercosis.
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Data availability
Underlying data
No data are associated with this article.
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